Grundinformationen
- Standard-SMILES
[O-][N+]1(C/C=C/c2ccccc2)CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1- InChIKey
CFOFJASKAOBSRJ-QPJJXVBHSA-N- Summenformel
- C26H26F2N2O
- Durchschnittliche Molmasse
- 420,5 g/mol
Namen und Bezeichner
- Bevorzugter Name
- 4-(bis(4-Fluorophenyl)methyl)-1-cinnamylpiperazine 1-Oxide
- IUPAC
- 4-[bis(4-fluorophenyl)methyl]-1-oxido-1-[(E)-3-phenylprop-2-enyl]piperazin-1-ium
- Englischer Name
- Flunarizine N-oxide dihydrochloride
- Summenformel
- C26H26F2N2O
- Molmasse
- 420.5
Namen und Synonyme
123375-94-0Flunarizine N-Oxide Dihydrochloride4-(bis(4-Fluorophenyl)methyl)-1-cinnamylpiperazine 1-Oxide123375-94-0(free base)Flunarizine N-OxideFlunarizine Impurity N14-(bis(4-fluorophenyl)methyl)-1-cinnamylpiperazine 1-oxide dihydrochloridePiperazine, 1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-, 4-oxide, (E)- (9CI)Flunarizine Impurity 1Flunarizine Impurity G4-(Bis(4-fluorophenyl)methyl)-1-cinnamylpiperazine 1-oxide (Flunarizine Impurity)
Datenbank-Bezeichner
- CAS
123375-94-0- EC Number
- 935-381-0
- Nikkaji
- J2.150.207C
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 5
- Polarare Oberfläche (TPSA)
- 21,3 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 31
- Formalladung
- 0
- Komplexität
- 534
Physikochemische Eigenschaften
- pka
- 5.09 · 5.09±0.20(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Chemie und Industrie
Anwendungen
Verwenden4-(bis(4-Fluorophenyl)methyl)-1-cinnamylpiperazine 1-oxide is used in the simulation of phase I metabolic reactions of selected calcium channel blockers by human liver microsomes and photochemical methods with the use of Q-TOF LC/MS
Anbieter31 Anbieter
天津始加生物医药科技有限公司15022261580 · [email protected]
济南百隆化学有限公司[email protected] · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
怀化元研达生物技术有限责任公司18711085600 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
广州佳途科技股份有限公司81960175 18933936954 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
Sinco Pharmachem (ShenZhen) R&D Co., Ltd.+86-18603013401 · [email protected]
怀化元研达生物技术有限责任公司18711085600; 18229999901 · [email protected]
希瓦生物科技(广州)有限公司13268215580 · [email protected]
上海柯维化学技术有限公司021-64609169 18901607656 · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
上海尺水药物研究有限公司[email protected] 13564957716 · [email protected]
Moxin Chemicals+86-17320513646 +86-17320513646 · [email protected]
杭州云易国科生物科技有限公司18457506494 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
湖北扬信医药科技有限公司15347293736 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
深圳摩科生化科技有限公司18627923403 · [email protected]
梯尔希(南京)药物研发有限公司18012923235 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
河南誉康卓宁进出口有限公司13393721940 · [email protected]
Standardpharm Co. Ltd.86-714-3992388 · [email protected]
深圳菲斯生物科技有限公司0755-4000505016 13380397412 · [email protected]
湖北瑞诺医药科技有限公司13165688766 · [email protected]
北京爱科姆科技有限公司17710328343 · [email protected]
深圳博泰尔生物技术有限公司13316949107 13316968096 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
常州翔龙医药科技有限公司18661161657 · [email protected]
深圳瑞恺德生物科技有限公司0755-61348847 17820674378 · [email protected]
上海择睿生物科技有限公司021-54580889 18321124657 · [email protected]
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Verknüpfte Notizen
Wird geladen…